Estrace combined with Prempro

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Breast Cancer Female Other Serious 12/12/2003 Female 1/3/2006 Lawyer United States
Primary
Secondary
Neoplasm Malignant Other Serious Female 1/11/2006 Consumer United States
Primary
Secondary
Ovarian Cancer Other Serious 1/9/2004 Female 1/17/2006 Consumer United States
Primary
Secondary
Ovarian Cancer Other Serious 1/9/2004 Female 1/16/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 3/19/2003 64 Female 154 lb 1/24/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 9/12/2002 63 Female 216 lb 1/31/2006 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 1/14/2002 54 Female 1/31/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious Female 2/1/2006 Consumer United States
Primary
Secondary
Breast Cancer In Situ Other Serious Female 1/27/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 1/31/2006 United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2003 Female 2/3/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 74 Female 2/6/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 2/1/2006 United States
Primary
Secondary
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 2/1/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 4/20/2001 54 Female 503 lb 2/7/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 6/26/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 7/19/2002 66 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/25/2002 64 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/1/2001 54 Female 120 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Ovarian Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 7/18/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 5/1/1997 56 Female 150 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 11/21/1995 61 Female 130 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 12/23/1998 46 Female 188 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/3/2002 56 Female 130 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 4/10/2004 58 Female 12/23/2005 United States
Primary
Secondary
Transient Ischaemic Attack Other Serious 10/8/2003 63 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 7/21/1999 69 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2003 60 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/1999 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/30/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/9/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/10/1998 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/5/2005 64 Female 12/23/2005 United States
Primary
Secondary
Ovarian Cancer Other Serious 3/31/2003 63 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 4/29/2004 60 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/8/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Female Required Intervention Female 2/3/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/4/2002 Female 12/23/2005 United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 1/21/1999 74 Female 2/7/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2004 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 2/14/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2002 Female 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 12/8/2003 Female 12/23/2005 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 4/10/2001 54 Female 220 lb 2/10/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 8/26/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/16/1999 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/1998 58 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/27/1999 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/14/1999 64 Female 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 11/1/2003 63 Female 12/23/2005 United States
Primary
Secondary
Cerebrovascular Accident Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/24/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/10/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/15/2003 61 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2000 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 7/1/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 5/1/2003 Female 12/23/2005 United States
Primary
Secondary
Gallbladder Cancer Other Serious 11/1/2000 Female 2/20/2006 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 2/21/2001 55 Female 2/22/2006 Consumer United States
Primary
Secondary
Deep Vein Thrombosis Other Serious 6/29/1995 57 Female 2/22/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 3/15/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/2/2003 62 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 8/11/2003 77 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2000 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2000 63 Female 100 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 6/12/2001 63 Female 150 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 8/1/2002 62 Female 142 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/8/2003 66 Female 130 lb 2/27/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious Female 3/3/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 9/18/2003 61 Female 3/3/2006 Consumer United States
Primary
Secondary
Metastases To Lymph Nodes Other Serious Female 2/28/2006 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/1999 65 Female 140 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 2/26/2004 59 Female 3/8/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 4/25/2002 Female 3/13/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 8/1/2000 52 Female 185 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/1998 61 Female 145 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 11/15/2001 49 Female 140 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 6/18/2003 64 Female 12/23/2005 United States
Primary
Secondary
Depression Other Serious 1/1/2001 55 Female 125 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/1/2001 63 Female 158 lb 12/23/2005 United States
Primary
Secondary
Breast Tenderness Other Serious 9/1/2003 61 Female 182 lb 12/23/2005 United States
Primary
Secondary
Ovarian Cancer Death 1/9/2004 Female 3/10/2006 United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 6/29/1995 57 Female 160 lb 3/10/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 2/26/2004 59 Female 3/13/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 3/13/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 4/25/2002 Female 3/14/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 3/17/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious Female 3/17/2006 United States
Primary
Secondary
Breast Cancer Other Serious 12/4/1997 70 Female 3/28/2006 Lawyer United States
Primary
Secondary
Visual Disturbance Other Serious 1/1/2001 49 Female 170 lb 3/29/2006 Lawyer United States
Primary
Concomitant
Progesterone Receptor Assay Positive Other Serious 12/4/1997 70 Female 3/28/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/2/2001 64 Female 4/11/2006 Lawyer United States
Primary
Secondary
Weight Increased Hospitalization 10/13/1998 56 Female 172 lb 4/5/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 5/1/2000 Female 4/12/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 3/1/2002 Female 4/6/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 2/8/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 10/4/2002 Female 2/8/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 3/1/2002 Female 4/11/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 6/2/2001 64 Female 4/12/2006 United States
Primary
Secondary
Neoplasm Malignant Other Serious 12/14/1995 54 Female 190 lb 4/18/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 5/1/2000 Female 4/19/2006 Lawyer United States
Primary
Secondary
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 4/21/2006 Physician United States
Primary
Secondary
Concomitant
Visual Disturbance Other Serious 1/1/2001 49 Female 170 lb 5/4/2006 Physician United States
Primary
Concomitant
Breast Cancer Female Other Serious 5/1/2000 Female 5/3/2006 Lawyer United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 7/18/2003 57 Female 122 lb 5/5/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 5/1/2000 Female 5/12/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 5/1/2000 Female 5/11/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 3/21/2002 71 Female 124 lb 5/11/2006 United States
Primary
Secondary
Breast Cancer Required Intervention 4/29/2004 60 Female 3/7/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 12/4/2003 76 Female 5/24/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 6/26/2001 73 Female 5/24/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 4/4/2005 57 Female 5/25/2006 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 12/4/2003 76 Female 5/23/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 6/26/2001 73 Female 5/24/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 5/28/2002 67 Female 130 lb 5/24/2006 United States
Primary
Secondary
Breast Cancer Other Serious 5/3/2001 63 Female 5/31/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 10/31/2000 Female 6/1/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 4/4/2005 57 Female 5/30/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 12/16/1999 Female 5/31/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 10/31/2000 Female 5/31/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 6/8/2006 Consumer United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 5/3/2001 63 Female 6/1/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2002 60 Female 6/9/2006 Consumer United States
Primary
Secondary
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 6/1/2006 Physician United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 3/21/2002 71 Female 124 lb 6/16/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 5/28/2002 67 Female 130 lb 6/16/2006 Lawyer United States
Primary
Secondary
Ovarian Cancer Other Serious 6/24/2003 Female 6/23/2006 Consumer United States
Primary
Secondary
Ovarian Cancer Other Serious 6/24/2003 Female 6/21/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 6/4/2002 Female 6/29/2006 Lawyer United States
Primary
Secondary
Scar Other Serious 5/9/2002 67 Female 130 lb 6/27/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 6/4/2002 Female 6/29/2006 Lawyer United States
Primary
Secondary
Ovarian Cancer Other Serious 6/24/2003 Female 6/26/2006 United States
Primary
Secondary
Ovarian Cancer Other Serious 6/24/2003 Female 6/28/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 12/8/2003 66 Female 6/30/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2002 56 Female 6/30/2006 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 6/4/2002 Female 7/3/2006 United States
Primary
Secondary
Ovarian Cancer Other Serious Female 7/12/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 3/3/2001 74 Female 7/12/2006 Consumer United States
Primary
Secondary
Ovarian Cancer Metastatic Other Serious 8/1/2002 59 Female 162 lb 7/12/2006 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 8/1/1999 Female 7/18/2006 Lawyer United States
Primary
Secondary

Drug Data